Henry Meds Henry Meds built its reputation on straightforward, no-membership-fee pricing for compounded GLP-1 medications
Morgan Walker , RD, is a dietitian at Lebanon Valley College
Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network (2022) Changes in glucose metabolism and glycemic status with once-weekly subcutaneous semaglutide 2.4 mg among participants with prediabetes in the STEP program, Diabetes Care (2022) What causes obesity & overweight?, Eunice Kennedy Shriver National Institute of Child Health and Human Development (2021) Compounding and the FDA: Questions and Answers, Food and Drug Administration (2024) Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes, Reviews in Endocrine and Metabolic Disorders (2022) FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) Thinking of using a compounding pharmacy

Investigating How GLP-1 May Contribute to Hair Loss Though not a direct side effect, a few mechanisms might explain how GLP-1 medications could indirectly contribute to hair loss
Staying hydrated and taking injections on the same day each week also help reduce discomfort